INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS

Impact · against what's priced in

Evolus faces increased legal risk as a regulatory warning regarding Jeuveau's marketing evolves into a securities fraud investigation. While the FDA warning was already reflected in a recent 7.15% price drop, the potential for class action litigation introduces a new layer of financial and governance risk.

EOLS−0.30

No priced-in read yet